Patents by Inventor CURRY Ken

CURRY Ken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeted contrast agents comprising a hydrazide functional group
    Patent number: 10286090
    Abstract: Described herein is a contrast agent for administration to a subject. The contrast agent includes a targeting portion that includes a hydrazide functional group; a metal ion bound to a metal-complexable portion; and a linker joining the targeting portion and the metal-complexable portion of the contrast agent. The portion that is not bound to a metal ion localizes the contrast agent to necrotic tissue in the subject.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: May 14, 2019
    Assignee: RF Therapeutics Inc.
    Inventors: Zhang Jidong, Curry Ken
  • TARGETED CONTRAST AGENTS COMPRISING A HYDRAZIDE FUNCTIONAL GROUP
    Publication number: 20170340757
    Abstract: Described herein is a contrast agent for administration to a subject. The contrast agent includes a targeting portion that includes a hydrazide functional group; a metal ion bound to a metal-complexable portion; and a linker joining the targeting portion and the metal-complexable portion of the contrast agent. The portion that is not bound to a metal ion localizes the contrast agent to necrotic tissue in the subject.
    Type: Application
    Filed: December 10, 2015
    Publication date: November 30, 2017
    Inventors: ZHANG Jidong, CURRY Ken